Kolexia
Harlé Alexandre Pharmacien
Harlé Alexandre
Pharmacien
Institut de cancérologie de Lorraine
Vandoeuvre-lès-Nancy, France
162 Activités
1.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs colorectales Carcinomes Adénocarcinome Métastase tumorale Mélanome Tumeurs du poumon Tumeurs de l'ovaire Tumeurs du pancréas

Collaborateurs

Voir plus
Merlin Jean-Louis
Merlin Jean-Louis
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Gilson Pauline
Gilson Pauline
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Leroux-Broussier Agnes
Leroux-Broussier Agnes
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Franczak Claire
Franczak Claire
Hôpital Robert Schuman, Vantoux, France

Industries

Voir plus
AstraZeneca
24 collaboration(s)
Dernière en 2023
GSK
22 collaboration(s)
Dernière en 2023
B3TSI
20 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
PERCIMEL: Personalized Circulating DNA Follow-up in Melanoma
Essai Clinique (Institut de cancérologie de Lorraine)   04 mars 2024
Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
Clinical and experimental medicine   17 janvier 2024
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles.
Cell reports. Medicine   22 décembre 2023
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS).
Biomedicines   28 novembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.
Scientific reports   31 octobre 2023
Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
Cancers   27 octobre 2023
160P CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
Molecular Analysis for Precision Oncology Congress 2023 4-6 October 2023   01 octobre 2023
2331P Interest of next generation sequencing (NGS) for integrated molecular diagnosis of HER2-low breast cancer
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023